K-V Pharma Reaches $7.5M Deal With Zydus Pharma

Law360, New York (October 22, 2012, 7:13 PM ET) -- K-V Pharmaceutical Co. asked a New York bankruptcy judge to approve a $7.5 million settlement between several of its subsidiaries and Zydus Pharmaceuticals (USA) Inc. and Nesher Pharmaceuticals (USA) LLC to resolve outstanding claims related to an asset purchase agreement.

K-V asked U.S. Bankruptcy Judge Allan L. Gropper to bless the deal between the Zydus parties and debtors K-V Pharmaceutical Co., K-V Generic Pharmaceuticals Inc. and DrugTech Corp., which is aimed at tying up the loose ends of the asset purchase agreement and related deals between...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required